Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001812786-22-000001
Filing Date
2022-12-15
Accepted
2022-12-15 10:08:31
Documents
1
Effectiveness Date
2022-12-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8756
  Complete submission text file 0001812786-22-000001.txt   9816
Mailing Address 250 WEST 55TH STREET FL 35 NEW YORK NY 10019
Business Address 250 WEST 55TH STREET FL 35 NEW YORK NY 10019 (212) 905-0197
Molecule Ventures LP (Filer) CIK: 0001812786 (see all company filings)

EIN.: 850631351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-368496 | Film No.: 221463870